Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Aug 10, 2014; 5(3): 194-196
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.194
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.194
Towards optimal treatment of ductal carcinoma in situ
Christina Choy, Kefah Mokbel, The London Breast Institute, The Princess Grace Hospital, London W1U 5NY, United Kingdom
Author contributions: Both authors contributed equally to the article.
Correspondence to: Kefah Mokbel, Lead Breast Surgeon and Professor of Breast Cancer Surgery, The London Breast Institute, The Princess Grace Hospital, 42-52 Nottingham Place, London W1U 5NY, United Kingdom. kefahmokbel@hotmail.com
Telephone: +44-207-9082040 Fax: +44-207-9082275
Received: October 14, 2013
Revised: April 28, 2014
Accepted: May 29, 2014
Published online: August 10, 2014
Processing time: 288 Days and 8.5 Hours
Revised: April 28, 2014
Accepted: May 29, 2014
Published online: August 10, 2014
Processing time: 288 Days and 8.5 Hours
Core Tip
Core tip: Localized ductal carcinoma in situ (DCIS) is treated with adequate local excision followed by radiotherapy (RT) in most cases whereas extensive disease is treated with mastectomy (± immediate reconstruction). RT may be safely omitted in some patients with adequately excised low risk DCIS.